Every drug follows the same 12-point structure: generic name, Indian brand names, drug class, mechanism of action, indications, dosage and route with adult, paediatric and renal or hepatic adjustments, contraindications, frequency-graded side effects, clinically significant interactions, pregnancy category, high-yield exam pearls, and clinical notes.

Because the structure is identical for every entry, you always know where to look. Searching by generic name, brand name, or drug class returns the same clear profile every time.

Take metformin as an example. The profile lists Indian brands such as Glyciphage, Glucophage and Obimet, classifies it as a biguanide antidiabetic, and explains the mechanism: activation of AMP-kinase, reduced hepatic glucose output, and increased peripheral insulin sensitivity.

The standard dose is given as 500mg twice to three times daily with meals, up to a maximum of 2500mg per day, with the clinical pearl that metformin is the drug of choice in type 2 diabetes, does not cause hypoglycaemia, and carries lactic acidosis as its feared adverse effect.